Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin vs Octreotide in Bleeding Esophageal Varices
NCT00534677Phase 4Completed
- Sponsor
- Aga Khan University
- Start
- May 2004
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terlipressin, Octreotide long-acting injection in Esophageal variceal hemorrhage (EVH), sponsored by Aga Khan University. Started May 2004; status: completed.
02
Drugs
terlipressinOctreotide long-acting injection
03
Conditions
Esophageal variceal hemorrhage (EVH)
Beyond the preview
Go deeper on NCT00534677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534677.